The research interests of Matthew A. Bernstein, Ph.D., are in the field of MRI.
Dr. Bernstein has a special focus on:
- Development of novel MRI systems and software, including a lightweight, high-field system for head imaging
- Development of MRI biomarkers (within the laboratory of Clifford R. Jack Jr., M.D.) to monitor Alzheimer's disease in multicenter studies and clinical trials
Significance to patient care
The purpose of the novel, lightweight MRI system is to allow the deployment of low-cost, high-quality MRI scanners to locations where they previously have not been available.
The goal of the imaging biomarker work is to provide imaging tools to researchers so that they may more rapidly assess therapies and repeatedly improve upon them to find effective, new treatments for Alzheimer's disease.
- Editor in Chief, Magnetic Resonance in Medicine, 2011-present
- Fellow (2009) and Member of the Board of Trustees (2011-present), International Society for Magnetic Resonance in Medicine
- Member of the Board of Directors and Board Examiner, American Board of Medical Physics, 2010-present
- Author (with William Friedman), "Thinking About Equations: A Practical Guide for Developing Mathematical Intuition in the Physical Sciences and Engineering," 2009
- Author (with Kevin King and X. Joe Zhou), "Handbook of MRI Pulse Sequences," 2004